R Kunert

Summary

Affiliation: University of Natural Resources and Applied Life Sciences
Country: Austria

Publications

  1. ncbi Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody
    Renate Kunert
    Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, A 1190 Vienna, Austria
    AIDS Res Hum Retroviruses 20:755-62. 2004
  2. ncbi Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells
    R Kunert
    Institute of Applied Microbiology, University of Agricultural Sciences, Muthgasse 18, Haus B, A 1190 Vienna, Austria
    Biotechnol Bioeng 67:97-103. 2000
  3. ncbi Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting
    N Borth
    Institute for Applied Microbiology, University of Agriculture and Forestry, Muthgasse 18, 1190 Vienna, Austria
    Biotechnol Bioeng 71:266-73. 2000
  4. ncbi A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
    G Stiegler
    Institute of Applied Microbiology, University of Agricultural Sciences, A 1190 Vienna, Austria
    AIDS Res Hum Retroviruses 17:1757-65. 2001
  5. ncbi Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by northern blot and flow cytometry
    N Borth
    Institute for Applied Microbiology, University of Agriculture, Vienna, Austria
    J Biotechnol 67:57-66. 1999
  6. ncbi Analysis of alterations in gene expression after amplification of recombinant genes in CHO cells
    J Grillari
    Institute of Applied Microbiology, University of Agricultural Sciences, Muthgasse 18, A 1190, Vienna, Austria
    J Biotechnol 87:59-65. 2001
  7. ncbi Humanization strategies for an anti-idiotypic antibody mimicking HIV-1 gp41
    A Mader
    Department of Biotechnology, Institute for Applied Microbiology, BOKU University of Natural Resources and Applied Life Sciences, Muthgasse 11, A 1190 Vienna, Austria
    Protein Eng Des Sel 23:947-54. 2010
  8. ncbi Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures
    Markus Sack
    Institute of Molecular Biotechnology, RTWH Aachen University, Worringerweg 1, 52074 Aachen, Germany
    FASEB J 21:1655-64. 2007
  9. ncbi Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5
    Johannes S Gach
    Institute of Applied Microbiology, Department of Biotechnology, University of Natural Resources and Applied Life Sciences, Muthgasse 18, A 1190 Vienna, Austria
    Mol Immunol 45:1027-34. 2008
  10. ncbi High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris
    Johannes S Gach
    Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, Muthgasse 18, A 1190 Vienna, Austria
    J Biotechnol 128:735-46. 2007

Collaborators

Detail Information

Publications50

  1. ncbi Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody
    Renate Kunert
    Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, A 1190 Vienna, Austria
    AIDS Res Hum Retroviruses 20:755-62. 2004
    ..The antiviral activity could be greatly enhanced by change of IgG(3) to IgG(1). In contrast, the IgM isotype almost completely lost its neutralizing potential...
  2. ncbi Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells
    R Kunert
    Institute of Applied Microbiology, University of Agricultural Sciences, Muthgasse 18, Haus B, A 1190 Vienna, Austria
    Biotechnol Bioeng 67:97-103. 2000
    ..CHO clones have been established, which stably express humAb 2F5 at high levels. The specificity, affinity and in vitro function of both isotypes were identical...
  3. ncbi Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting
    N Borth
    Institute for Applied Microbiology, University of Agriculture and Forestry, Muthgasse 18, 1190 Vienna, Austria
    Biotechnol Bioeng 71:266-73. 2000
    ..4 microM), the clones isolated by sorting were already homogeneous at 0.8 microM methotrexate...
  4. ncbi A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
    G Stiegler
    Institute of Applied Microbiology, University of Agricultural Sciences, A 1190 Vienna, Austria
    AIDS Res Hum Retroviruses 17:1757-65. 2001
    ..Moreover, our results suggest that 4E10 should be further investigated for passive anti-HIV immunotherapy...
  5. ncbi Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by northern blot and flow cytometry
    N Borth
    Institute for Applied Microbiology, University of Agriculture, Vienna, Austria
    J Biotechnol 67:57-66. 1999
    ..During long time cultivation of the heterohybridoma cell line a continuous decrease in light and heavy chain production was seen without the appearance of a non producing sub-population...
  6. ncbi Analysis of alterations in gene expression after amplification of recombinant genes in CHO cells
    J Grillari
    Institute of Applied Microbiology, University of Agricultural Sciences, Muthgasse 18, A 1190, Vienna, Austria
    J Biotechnol 87:59-65. 2001
    ..Furthermore, an alternatively spliced, non-functional form of the DHFR mRNA was detected, suggesting a dramatic increase of the selection pressure exerted by MTX...
  7. ncbi Humanization strategies for an anti-idiotypic antibody mimicking HIV-1 gp41
    A Mader
    Department of Biotechnology, Institute for Applied Microbiology, BOKU University of Natural Resources and Applied Life Sciences, Muthgasse 11, A 1190 Vienna, Austria
    Protein Eng Des Sel 23:947-54. 2010
    ..In this study, we developed humanized Ab2/3H6 variants that retained the same affinity as the parental antibody, and are therefore of potential interest for future clinical trails...
  8. ncbi Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures
    Markus Sack
    Institute of Molecular Biotechnology, RTWH Aachen University, Worringerweg 1, 52074 Aachen, Germany
    FASEB J 21:1655-64. 2007
    ..This highlights important issues raised by the use of plant systems to produce human biologics...
  9. ncbi Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5
    Johannes S Gach
    Institute of Applied Microbiology, Department of Biotechnology, University of Natural Resources and Applied Life Sciences, Muthgasse 18, A 1190 Vienna, Austria
    Mol Immunol 45:1027-34. 2008
    ..Moreover, we report about an immunisation study with Ab2/3H6 Fab variants, which elicited a specific 2F5-like humoral immune response in BALB/c mice...
  10. ncbi High level expression of a promising anti-idiotypic antibody fragment vaccine against HIV-1 in Pichia pastoris
    Johannes S Gach
    Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, Muthgasse 18, A 1190 Vienna, Austria
    J Biotechnol 128:735-46. 2007
    ..Biochemical analysis confirmed that the N-glycosylation does not contribute to the binding properties of 3H6...
  11. ncbi Protein-free transfection of CHO host cells with an IgG-fusion protein: selection and characterization of stable high producers and comparison to conventionally transfected clones
    Christine Lattenmayer
    Austrian Center of Biopharmaceutical Technology, Muthgasse 18, 1190 Vienna, Austria
    Biotechnol Bioeng 96:1118-26. 2007
    ....
  12. ncbi Biochemical characterization of rhEpo-Fc fusion protein expressed in CHO cells
    Kornelia Schriebl
    Austrian Center of Biopharmaceutical Technology, Muthgasse 18, A 1190 Vienna, Austria
    Protein Expr Purif 49:265-75. 2006
    ..The direct comparison with other rhEpo-Fc fusion proteins failed, because no appropriate data were found in the literature...
  13. ncbi Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells
    Evelyn Trummer
    Department of Biotechnology, Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences Vienna, Muthgasse 18, 1190 Vienna, Austria
    Biotechnol Bioeng 94:1045-52. 2006
    ....
  14. ncbi Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly single-GlcNAc N-glycans
    Thomas Rademacher
    Institute for Molecular Biotechnology, Biology VII, RWTH Aachen, Worringerweg 1, 52074 Aachen, Germany
    Plant Biotechnol J 6:189-201. 2008
    ....
  15. ncbi Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data
    Brigitta Vcelar
    Polymun Scientific, Vienna bImmunology Outpatient Clinic, Vienna, Austria
    AIDS 21:2161-70. 2007
    ..The broadly neutralizing recombinant human HIV-1 antibodies 4E10, 2F5 and Igh1b12 are reported to have autoreactive potential, which is significant for HIV-1 vaccine development and passive immunotherapy using these antibodies...
  16. ncbi Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern
    Matthias Schähs
    Institute of Applied Genetics and Cell Biology, BOKU Wien, Austria
    Plant Biotechnol J 5:657-63. 2007
    ..Our results demonstrate the feasibility of a knockout strategy for N-glycan engineering of plants towards mammalian-like structures, thus providing a significant improvement in the use of plants as an expression platform...
  17. ncbi Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6
    Steve Bryson
    Department of Biochemistry, University of Toronto, 1 King s College Circle, Toronto, Ontario, Canada M5S 1A8
    J Mol Biol 382:910-9. 2008
    ..This defines Ab2/3H6 as an anti-idiotypic antibody of the Ab2gamma class, i.e., an antigen-inhibitable idiotype that does not carry the internal image of the linear primary gp41 (662)ELDKWAS(668) epitope...
  18. ncbi Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides
    Johannes Stadlmann
    Department of Chemistry, University of Natural Resources and Applied Life Sciences BOKU, Vienna, Austria
    Proteomics 8:2858-71. 2008
    ..Regarding fast and yet detailed structural assignment, LC-MS on graphitic carbon supersedes all other current methods...
  19. ncbi The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5
    Nerea Huarte
    Unidad de Biofisica CSIC UPV EHU, Universidad del Pais Vasco, Aptdo 644, 48080 Bilbao, Spain
    J Virol 82:8986-96. 2008
    ..We conclude that the capacity to interfere with the membrane activity of conserved MPER sequences is best correlated with the broad neutralization of the 4E10 MAb...
  20. ncbi Transcriptional profiling of phenotypically different Epo-Fc expressing CHO clones by cross-species microarray analysis
    Evelyn Trummer
    Department of Biotechnology, Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences Vienna, Vienna, Austria
    Biotechnol J 3:924-37. 2008
    ..These promising results will further increase our efforts to develop CHO specific microarrays that deliver information about the suitability of a clone candidate for industrial production...
  21. ncbi Expression, purification, and in vivo administration of a promising anti-idiotypic HIV-1 vaccine
    Johannes Simon Gach
    Institute of Applied Microbiology, Department of Biotechnology, University of Natural Resources and Applied Life Sciences, Muthgasse 18, A 1190 Vienna, Austria
    Mol Biotechnol 39:119-25. 2008
    ..The crude sera were screened for specific antibodies against the epitope of mAb 2F5 ELDKWA as well as for reactivity against HIV-1 gp41...
  22. ncbi A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits
    Chunsheng Jin
    Department of Chemistry, University of Natural Resources and Applied Life Sciences, Muthgasse 18, 1190 Vienna, Austria
    Glycobiology 18:235-41. 2008
    ..This emphasizes the need for the use of glyco-engineered plants lacking any potentially antigenic N-glycan structures for the production of plant-derived recombinant proteins intended for parenteral human application...
  23. ncbi Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine?
    Johannes S Gach
    Institute of Applied Microbiology, Department of Biotechnology, University of Natural Resources and Applied Life Sciences, A 1190 Vienna, Austria
    AIDS Res Hum Retroviruses 23:1405-15. 2007
    ..Moreover, the inhibition potency of chimeric Ab2/3H6 analyzed by in vitro studies could be shown to be the same as that detected for the hybridoma-derived murine Ab2/3H6...
  24. ncbi Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors
    Evelyn Trummer
    Department of Biotechnology, Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences Vienna, Muthgasse 18, 1190 Vienna, Austria
    Biotechnol Bioeng 94:1033-44. 2006
    ..The well directed alteration of the process environment has emerged as a tool adequate for further process optimization applying a biphasic cultivation strategy...
  25. ncbi Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
    Rosa M F Cardoso
    Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA
    Immunity 22:163-73. 2005
    ..These structural insights should assist in the design of immunogens to elicit 4E10-like neutralizing responses...
  26. ncbi Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1
    Michael B Zwick
    Department of Immunology IMM 2, The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA 92037, USA
    J Virol 79:1252-61. 2005
    ..Neutralization experiments showing synergy between and T20 and 4E10 against HIV-1 are also presented. The data presented may aid in the design of antigens that better present the MPER of gp41 to the immune system...
  27. ncbi Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
    James M Binley
    IMM2, Department of Immunology, The Scripps Research Institute, 10550 N Torrey Pines Rd, La Jolla, CA 92037, USA
    J Virol 78:13232-52. 2004
    ..As well as the significance for vaccine design, our data have implications for passive-immunization studies in countries where clade C viruses are common, given that only MAbs b12 and 4E10 were effective against viruses from this clade...
  28. ncbi Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12
    Susanne Wolbank
    Institute of Applied Microbiology, University of Agriculture, A-1190 Vienna, Austria
    J Virol 77:4095-103. 2003
    ....
  29. ncbi The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5
    Michael B Zwick
    Department of Immunology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA
    J Virol 78:3155-61. 2004
    ..These observations present a challenge to vaccine strategies based on peptide mimics of the linear epitope...
  30. ncbi Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes
    Eve de Rosny
    Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892-4555, USA
    J Virol 78:2627-31. 2004
    ..We also demonstrate conformational changes in the C heptad of gp41...
  31. ncbi Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
    Daniel A Calarese
    Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
    Science 300:2065-71. 2003
    ..The unique interdigitation of Fab domains within an antibody uncovers a previously unappreciated mechanism for high-affinity recognition of carbohydrate or other repeating epitopes on cell or microbial surfaces...
  32. ncbi Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
    Barton F Haynes
    Duke University School of Medicine, Durham, NC 27710, USA
    Science 308:1906-8. 2005
    ..These results may have important implications for generating effective neutralizing antibody responses by using HIV-1 vaccines...
  33. ncbi Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation
    Gabriela Stiegler
    Institute of Applied Microbiology, University of Agricultural Sciences, Muthgasse, Vienna, Austria
    AIDS 16:2019-25. 2002
    ..However, the antiviral effects of antibody treatment have not been fully analyzed in this first clinical trial...
  34. ncbi Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line
    Nicole Borth
    Institute for Applied Microbiology, University of Natural Resources and Applied Life Sciences, Muthgasse 18, 1190 Vienna, Austria
    Biotechnol Prog 21:106-11. 2005
    ..Overexpression of BIP, both alone and in combination with PDI, reduced the specific secretion rate, whereas PDI, when overexpressed alone, caused an increase of product secretion rate...
  35. ncbi Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice
    Yan Zeng
    , University Medicine, 13353 Berlin, Germany
    Mol Immunol 42:1311-9. 2005
    ..In vivo depletion of NK-cells completely abrogated this effect, suggesting that the mechanism involved in the ch14.18/CHO induced anti-neuroblastoma effect is mediated by NK-dependent ADCC...
  36. ncbi HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies
    Sabine Nakowitsch
    Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, Vienna, Austria
    AIDS 19:1957-66. 2005
    ....
  37. ncbi Validated method for quantification of genetically modified organisms in samples of maize flour
    Renate Kunert
    Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, Muthgasse 18, A 1190 Vienna, Austria
    J Agric Food Chem 54:678-81. 2006
    ..The results were evaluated with ValiData for homology of variance, linearity, accuracy of the standard curve, and standard deviation...
  38. ncbi Engineering of Pichia pastoris for improved production of antibody fragments
    Brigitte Gasser
    Institute of Applied Microbiology, BOKU University of Natural Resources and Applied Life Sciences Vienna, Muthgasse 18, A-1190 Vienna, Austria
    Biotechnol Bioeng 94:353-61. 2006
    ..3-fold, PDI enabled an increase of the Fab level by 1.9-fold. Hence, the formation of interchain disulfide bonds can be seen as a major rate limiting factor to Fab assembly and subsequent secretion...
  39. ncbi Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides
    Marc Egelhofer
    Institute for Biomedical Research Georg-Speyer-Haus, Frankfurt a. M. Medizinische Hochschule Hannover, Hannover, Germany
    J Virol 78:568-75. 2004
    ..Preclinical toxicity and efficacy studies of this antiviral vector have been completed, and clinical trials are in preparation...
  40. ncbi A novel strategy for quantitative isoform detection directly performed from culture supernatant
    Kornelia Schriebl
    Austrian Center of Biopharmaceutical Technology, Muthgasse 18, A 1190 Vienna, Austria
    J Pharm Biomed Anal 42:322-7. 2006
    ..A fundamental benefit of this technique is the ability to perform quantitative isoform pattern analysis directly from serum-free culture supernatant...
  41. ncbi Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12
    K H Roux
    Department of Biological Science, 2nd Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306 4307, USA
    Mol Immunol 41:1001-11. 2004
    ..Efforts to identify IgG molecules with a similar intertwined Fab dimer structure in a large IgG pool were unsuccessful...
  42. ncbi A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120
    Alfredo Menendez
    Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada
    FASEB J 22:1380-92. 2008
    ..Moreover, 2G12.1 peptide is not an immunogenic mimic of the 2G12 epitope, since antisera produced against it did not bind gp120...
  43. ncbi Recognition and blocking of HIV-1 gp41 pre-transmembrane sequence by monoclonal 4E10 antibody in a Raft-like membrane environment
    Maier Lorizate
    , University of the Basque Country, P. O. Box 644, 48080 Bilbao, Spain
    J Biol Chem 281:39598-606. 2006
    ..This work comprises the first experimental report on a lipid-modulated antibody capacity to bind a membrane-bound epitope sequence and arrest its restructuring activity...
  44. ncbi Characterisation of recombinant CHO cell lines by investigation of protein productivities and genetic parameters
    Christine Lattenmayer
    Austrian Center of Biopharmaceutical Technology, Muthgasse 18, 1190 Vienna, Austria
    J Biotechnol 128:716-25. 2007
    ..Nevertheless, a wider range of cell lines has to be investigated in order to implement genetic analyses into a screening process...
  45. ncbi Applicability of different fluorescent dyes for isoform quantification on linear IPG gels
    Kornelia Schriebl
    Austrian Center of Biopharmaceutical Technology, Vienna, Austria
    Electrophoresis 28:2100-7. 2007
    ..g., clone screening, process optimization, and purification monitoring...
  46. ncbi Improvement of the energy metabolism of recombinant CHO cells by cell sorting for reduced mitochondrial membrane potential
    Georg Hinterkörner
    Institute for Applied Microbiology, Department of Biotechnology, Universität für Bodenkultur, Muthgasse 18, Vienna, Austria
    J Biotechnol 129:651-7. 2007
    ..The potential of using flow cytometric cell sorting methods based on physiological activity for cell line optimisation is discussed...